Miguel-Angel Perales on Graft Versus Host Disease
Miguel-Angel Perales, MD, deputy chief, Adult Bone Marrow Transplant Service, director, Adult Bone Marrow Transplantation Fellowship Program, Memorial Sloan Kettering Cancer Center, discusses graft versus host disease (GVHD) after a bone marrow transplant.
Miguel-Angel Perales, MD, deputy chief, Adult Bone Marrow Transplant Service, director, Adult Bone Marrow Transplantation Fellowship Program, Memorial Sloan Kettering Cancer Center, discusses graft versus host disease (GVHD) after a bone marrow transplant.
A bone marrow transplant remains a critical treatment approach for patients with acute leukemia and myelodysplastic syndromes, but can be associated with complications such as GVHD.
GVHD happens when the donor's
white blood cells (T cells) attack the patient’s organs, which can cause many problems, Perales says.
A national phase III study being run by the Blood and Marrow Transplant Clinical Trials Network is evaluating GVHD relapse-free survival in patients 1 year after transplant to hopefully reduce complications from transplant.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).
